The Government of India, through the National Pharmaceutical Pricing
Authority (NPPA), has capped the trade margin at 30% on 137 anti-cancer
medicines. The aim is to make cancer treatment more affordable for patients.
17 Oct 2026Order published in the Gazette of India
9 Nov 2026Revised prices come into effect
Patients and partners with questions about the revised prices are welcome
to speak to their doctor, pharmacist or hospital.
